IRegained is a digital neurotherapeutics (DTx) company that has developed an FDA-registered, patented, smart, digital rehabilitation system that helps patients “rewire” their brain through the power of neuroplasticity, empowering people who have suffered a stroke, TBI or musculoskeletal injury, reclaim unassisted use of their hands. The MyHand® System has been clinically validated and is now available for commercial sale.
The System is a “smart”, cloud-connected, mechatronic device with clinically-effective, targeted finger and hand training protocols that enhance neuroplasticity and accelerate recovery of lost hand function.
Patients have demonstrated an improved ability to grasp and perform basic activities of daily living after only a few weeks of therapy. The System also incorporates a scientifically robust, engaging and gamified interface to promote neuroplasticity and encourage adherence to rehabilitation plans.
Founder & CEO
COO & VP Business Development
Head, Strategic Partnerships
Intellectual Property
Fundraising
In Market
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?
The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.
Applications are open from June 16 to July 7, 2025.